The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
Open Access
- 4 October 2007
- journal article
- research article
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 5 (1) , 56
- https://doi.org/10.1186/1477-7525-5-56
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Analysis of Safety and Tolerability Data Obtained from Over 1,500 Patients Receiving Topiramate for Migraine Prevention in Controlled TrialsPain Medicine, 2007
- Migraine prevalence, disease burden, and the need for preventive therapyNeurology, 2007
- Assessing the Ability of Topiramate to Improve the Daily Activities of Patients With MigraineMayo Clinic Proceedings, 2006
- The impact of migraine on daily activities: effect of topiramate compared with placeboCurrent Medical Research and Opinion, 2006
- Removing Barriers to Appropriate Migraine Treatment: Formulary Limitations and Triptan Package SizeHeadache: The Journal of Head and Face Pain, 2005
- Topiramate Improves Health‐Related Quality of Life When Used to Prevent MigraineHeadache: The Journal of Head and Face Pain, 2005
- Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trialsInternational Journal Of Clinical Practice, 2005
- Topiramate in migraine prophylaxisZeitschrift für Neurologie, 2004
- Topiramate in Migraine PreventionArchives of Neurology, 2004
- Topiramate for Migraine PreventionA Randomized Controlled TrialJAMA, 2004